To further elucidate the mechanisms behind increased DNMT1 activity in plasma and its potential sources, we analyzed tissue microarray of 59 patients and evaluated the DNMT1 expression intensity in cancer regions and paired adjacent tissue using immunohistochemistry (IHC). Here, DNMT1 is linked to cancer.